Does TOFACITINIB Cause Therapy non-responder? 1,320 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,320 reports of Therapy non-responder have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.9% of all adverse event reports for TOFACITINIB.
1,320
Reports of Therapy non-responder with TOFACITINIB
0.9%
of all TOFACITINIB reports
416
Deaths
801
Hospitalizations
How Dangerous Is Therapy non-responder From TOFACITINIB?
Of the 1,320 reports, 416 (31.5%) resulted in death, 801 (60.7%) required hospitalization, and 619 (46.9%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 1,320 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which TOFACITINIB Alternatives Have Lower Therapy non-responder Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN